Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy
Thomas, F.; Cunningham, P.; Thomas, J.; Gross, U.; Gaskins, D.; Sash, C.; Parker, K.
Transplantation Proceedings 19(1 Pt 3): 1874-1878
1987
ISSN/ISBN: 0041-1345 PMID: 3547892 Document Number: 302800
Document emailed within 1 workday
Related Documents
Abouna, G.M.; Kumar, M.S.; Stephan, R.; Prior, J.E.; Lyons, P.; Bulova, S.I.; al-Abdullah, I.H. 1993: Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation Transplantation Proceedings 25(3): 2241-2242Light, J.A.; Alijani, M.R.; Biggers, J.A.; Oddenino, K.; Reinmuth, B. 1981: Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection Transplantation Proceedings 13(1 Part 1): 475-481
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793
Evans, D.M.; Fabre, J.W.; Millard, P.R.; Morris, P.J. 1979: Effect of splenectomy alone and in combination with antilymphocyte serum on renal allograft rejection in the rat Transplantation 27(6): 389-391
Bunchman, T.E.; Ham, J.M.; Sedman, A.B.; Kershaw, D.B.; Turcotte, J.G.; Campbell, D.A.; Punch, J.D.; Merion, R.M. 1994: Superior allograft survival in pediatric renal transplant recipients Transplantation Proceedings 26(1): 24-25
Brun, P.; Sterkers, G.; Maisin, A.; Benali, K.; Baudouin, V.; Macher, M.; Loirat, C. 1995: Flow-cytometry monitoring of antilymphocyte globulin therapy in pediatric renal transplantation Transplantation Proceedings 27(2): 1744-1745
Hammer, C.; Krebs, G.; Chaussy, C.; Pfeifer, K.; Schmidt, K.; Land, W.; Brendel, W. 1979: Mitigation of hyperacute rejection by antilymphocyte globulin (ALG) Transplantation Proceedings 11(1): 31-35
Widmer, U.; Frei, D.; Keusch, G.; Burger, H.R.; Largiader, F.; Binswanger, U. 1988: OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine a Transplantation Proceedings 20(5 Suppl 6: 90-95
Troppmann, C.; Almond, P.S.; Fasola, C.; Benedetti, E.; Gruessner, R.W.; Dunn, D.L.; Gores, P.F.; Payne, W.D.; Matas, A.J.; Najarian, J.S. 1994: Effect of Minnesota antilymphocyte globulin on T-lymphocytes and their subsets during induction therapy in pediatric renal transplantation Transplantation Proceedings 26(1): 26-27
Hourmant, M.; Buzelin, F.; Dubigeon, P.; Soulillou, J.P. 1987: High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy Transplantation Proceedings 19(1 Pt 3): 2113-2114
Tsuchida, A.; Thomson, N.M.; Salem, H.H.; Atkins, R.C.; Hancock, W.W. 1990: Serial monitoring shows plasma protein C and free protein S levels are decreased during human acute renal allograft rejection Transplantation Proceedings 22(5): 2134-2136
Merion, R.M.; White, D.J.; Calne, R.Y. 1983: Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression Transplantation Proceedings 15(4): 2172-2177
Ludwin, D.; White, N.; Tsai, S.; Smith, E.K. 1985: Sequential Minnesota antilymphoblast globulin and cyclosporine therapy after cadaver renal transplantation Transplantation Proceedings 17(4): 1943-1944
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196
Murase, N.; Kim, D.G.; Todo, S.; Cramer, D.V.; Fung, J.J.; Starzl, T.E. 1990: Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy Transplantation 50(2): 186-189
Spriewald, B.M.; Hugo, C. 2006: De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection Clinical Transplants 2006: 469-472
Valderrábano, F.; Anaya, F.; Robles, N.R.; Jofré, R. 1988: Sequential therapy with anti-thymocyte globulin and cyclosporine a in oligoanuric high-risk cadaveric kidney graft recipients Transplantation Proceedings 20(5 Suppl 6: 75-78
Nakaji, K.; Nakata, T.; Yasumura, T.; Ohmori, Y.; Oka, T.; Takada, K.; Muranishi, S. 1988: Prolongation of rat renal allograft survival by injection of a small dose of cyclosporine into the thoracic duct Transplantation Proceedings 20(2 Suppl 2: 298-300
Abouna, G.M.; Kumar, M.S.; White, A.G.; Daddah, S.; John, P.; Samhan, M.; Omar, O.F.; Kusma, G. 1984: Experience with 130 consecutive renal transplants in the Middle East with special reference to histocompatibility matching, antirejection therapy with antilymphocyte globulin (ALG), and prolonged preservation of imported cadaveric grafts Transplantation Proceedings 16(4): 1114-1117